Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) — Capital Reinvestment Ratio
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Capital Reinvestment Ratio of 0.25x as of June 2023, meaning it reinvests 0% of its operating cash flow (€2.10 Billion) in capital expenditures (€524.46 Million). See net asset quality index of Guangzhou Baiyunshan Pharmaceutical Hold to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Capital Reinvestment Ratio (2013–2024)
This chart tracks Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's Capital Reinvestment Ratio across 12 annual periods. Check Guangzhou Baiyunshan Pharmaceutical Hold (GU5) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2024)
Year-by-year Capital Reinvestment Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2024. For live market cap and broader valuation context, see Guangzhou Baiyunshan Pharmaceutical Hold (GU5) total market value.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.33x | €3.44 Billion | €1.13 Billion | ▼ -17.4% |
| 2023 | 0.40x | €4.10 Billion | €1.63 Billion | ▲ +100.7% |
| 2022 | 0.20x | €7.00 Billion | €1.38 Billion | ▼ -10.6% |
| 2021 | 0.22x | €5.67 Billion | €1.25 Billion | ▼ -85.2% |
| 2020 | 1.50x | €585.19 Million | €876.50 Million | ▲ +213.5% |
| 2019 | 0.48x | €5.02 Billion | €2.40 Billion | ▲ +420.8% |
| 2018 | 0.09x | €5.22 Billion | €478.62 Million | ▼ -14.5% |
| 2017 | 0.11x | €1.83 Billion | €196.77 Million | ▲ +19.8% |
| 2016 | 0.09x | €2.54 Billion | €228.03 Million | ▼ -66.2% |
| 2015 | 0.27x | €1.94 Billion | €515.34 Million | ▲ +30.1% |
| 2014 | 0.20x | €1.75 Billion | €356.70 Million | ▼ -22.2% |
| 2013 | 0.26x | €1.34 Billion | €350.35 Million | — |